The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Blinded by the Light: The Growing Complexity of p53
Open accessAbstract
While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transient stress leads to induction of p53 which activates DNA repair and leads to quiescence (Vousden and Prives, 2009; Kasteri et al., 2018).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Vousden and Prives, 2009
In the citing paper
“Consequently, p53 target genes become activated and drive cellular responses of tumor cells, which include cell cycle arrest, apoptosis and senescence. 2”
From Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death (2013) · cites this paper as [2]
In the citing paper
“p53 is a key transcriptional regulator that controls multiple signals by activating genes with roles in cell cycle arrest, senescence, apoptosis, metabolism, differentiation, and survival (Vousden and Prives, 2009).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Vousden and Prives, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
Moumen, A., Masterson, P., O'Connor, M. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.032 · Cited by 350
RetractedIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citationTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Self-citationTransactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Cited by
Sorted by citations
Items 601–700 of 1,016
Sun, X., Dyson, H. J., & Wright, P. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021456118 · Cited by 80
HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism
Conrad, E., Polonio-Vallon, T., Meister, M. T., Matt, S., Bitomsky, N., Herbel, C., Liebl, M. C., Greiner, V., Križnik, B., Schumacher, S. D., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.75 · Cited by 80
Alshatwi, A. A., Subash‐Babu, P., & Antonisamy, P. (2015) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2015.10.002 · Cited by 80
Grison, A., Mantovani, F., Comel, A., Agostoni, E., Gustincich, S., Persichetti, F., & Sal, G. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106198108 · Cited by 80
An Ultrahigh Affinity d -Peptide Antagonist Of MDM2
Zhan, C., Zhao, L., Wei, X., Wu, X., Chen, X., Yuan, W., Lu, W., Pazgier, M., & Lu, W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3005465 · Cited by 80
BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
Yue, X., Zhao, Y., Liu, J., Zhang, C., Yu, H., Wang, J., Zheng, T., Liu, L., Li, J., Feng, Z., et al. (2015) · eLife · doi:10.7554/elife.08401 · Cited by 81
Renner, G., Janoušková, H., Noulet, F., Koenig, V., Guérin, É., Bär, S., Nüesch, J. P. F., Rechenmacher, F., Neubauer, S., Kessler, H., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.131 · Cited by 80
Functions of p53 in pluripotent stem cells
Fu, X., Wu, S., Li, B., Xu, Y., & Liu, J. (2019) · Protein & Cell · doi:10.1007/s13238-019-00665-x · Cited by 80
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk
Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79
Roles of HAUSP-mediated p53 regulation in central nervous system development
Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., Canoll, P. D., & Gu, W. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.12 · Cited by 79
Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
Zhao, C. Y., Grinkevich, V., Nikulenkov, F., Bao, W., & Selivanova, G. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11545 · Cited by 79
p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., & Rotter, V. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-9 · Cited by 79
The Ubiquitin-Proteasome System Is Indispensable for the Maintenance of Muscle Stem Cells
Kitajima, Y., Suzuki, N., Nunomiya, A., Osana, S., Yoshioka, K., Tashiro, Y., Takahashi, R., Ono, Y., Aoki, M., & Nagatomi, R. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.009 · Cited by 79
Wang, X., Liang, W., Cramer, J. M., Leibowitz, B. J., Judge-Golden, C. P., Epperly, M. W., Greenberger, J. S., Wang, F., Li, L., Stelzner, M. G., et al. (2015) · Scientific Reports · doi:10.1038/srep08566 · Cited by 79
Li, Y., Ma, H., Hu, X., Qu, Y., Wen, X., Zhang, Y., & Xu, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01261-4 · Cited by 79
Hamard, P.-J., Barthelery, N. J., Hogstad, B., Mungamuri, S. K., Tonnessen-Murray, C. A., Carvajal, L. A., Senturk, E., Gillespie, V., Aaronson, S. A., Mérad, M., et al. (2013) · Genes & Development · doi:10.1101/gad.224386.113 · Cited by 79
Expanding the p53 regulatory network: LncRNAs take up the challenge
Grossi, E., Sánchez, Y., & Huarte, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.011 · Cited by 78
Oxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation
Peuget, S., Bonacci, T., Soubeyran, P., Iovanna, J., & Dusetti, N. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.28 · Cited by 78
Croft, D. R., Crighton, D., Samuel, M. S., Lourenço, F. C., Munro, J., Wood, J. M., Bensaad, K., Vousden, K. H., Sansom, O. J., Ryan, K. M., et al. (2010) · Cell Research · doi:10.1038/cr.2010.154 · Cited by 78
Self-citationMuscle ankyrin repeat proteins: their role in striated muscle function in health and disease
Kojić, S., Radojkovic, D. P., & Faulkner, G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.643857 · Cited by 78
Essential Roles of E3 Ubiquitin Ligases in p53 Regulation
Sane, S., & Rezvani, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020442 · Cited by 78
Supramolecular pseudo-block gene carriers based on bioreducible star polycations
Hu, Y., Yuan, W., Zhao, N., Ma, J., Yang, W., & Xu, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.092 · Cited by 77
PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress
Kuo, M.-L., Lee, M. B.-E., Tang, M., den Besten, W., Hu, S., Sweredoski, M. J., Hess, S. Y., Chou, C., Changou, C. A., Su, M., et al. (2016) · Scientific Reports · doi:10.1038/srep18846 · Cited by 77
The Mettl3 epitranscriptomic writer amplifies p53 stress responses
Raj, N., Wang, M., Seoane, J. A., Zhao, R. L., Kaiser, A. M., Moonie, N. A., Demeter, J., Boutelle, A. M., Kerr, C. H., Mulligan, A. S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.010 · Cited by 77
Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
Nguyen, T., Menéndez, D., Resnick, M. A., & Anderson, C. W. (2014) · Human Mutation · doi:10.1002/humu.22506 · Cited by 77
Adlakha, Y. K., & Saini, N. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.46 · Cited by 77
Growth hormone is a cellular senescence target in pituitary and nonpituitary cells
Chesnokova, V., Zhou, C., Ben-Shlomo, A., Zonis, S., Tani, Y., Ren, S.-G., & Melmed, S. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310589110 · Cited by 77
Zhu, Y., Yan, Y., Principe, D. R., Zou, X., Vassilopoulos, A., & Gius, D. R. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-15 · Cited by 77
Elkholi, R., Renault, T. T., Serasinghe, M. N., & Chipuk, J. E. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-16 · Cited by 77
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 77
Chen, H., Zhao, L., Kumazawa, M., Yamauchi, N., Shigeyoshi, Y., Hashimoto, S., & Hattori, M. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00008.2013 · Cited by 77
High and Low LET Radiation Differentially Induce Normal Tissue Damage Signals
Niemantsverdriet, M., van Goethem, M., Bron, R., Hogewerf, W., Brandenburg, S., Langendijk, J. A., van Luijk, P., & Coppes, R. P. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.057 · Cited by 77
Bublik, D. R., Bursać, S., Sheffer, M., Oršolić, I., Shalit, T., Tarcic, O., Kotler, E., Mouhadeb, O., Hoffman, Y., Fuchs, G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614876114 · Cited by 77
Wheaton, K., Campuzano, D., Ma, W., Sheinis, M., Ho, B., Brown, G. W., & Benchimol, S. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00659-16 · Cited by 77
Podralska, M., Ciesielska, S., Kluiver, J. L., van den Berg, A., Dzikiewicz‐Krawczyk, A., & Ślęzak-Prochazka, I. (2020) · Cancers · doi:10.3390/cancers12061662 · Cited by 76
Wang, J., Zhao, T., Chen, J., Kang, L., Wei, Y., Wu, Y., Han, L., Shen, L., Long, C., Wu, S., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124316 · Cited by 76
Ubiquitin ligases in cancer: Functions and clinical potentials
Duan, S., & Pagano, M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.008 · Cited by 77
The E3 Ligase Smurf1 Regulates Wolfram Syndrome Protein Stability at the Endoplasmic Reticulum
Guo, X. L., Shen, S., Song, S., He, S., Cui, Y., Xing, G., Wang, J., Yin, Y., Fan, L., He, F., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225615 · Cited by 76
p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
Yan, H., Wu, H., Zhang, H., Ashton, C., Tong, C., Wu, H., Qian, Q., Wang, H.-Y., & Ying, Q. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.029 · Cited by 76
Luo, Y., Hartford, S. A., Zeng, R., Southard, T. L., Shima, N., & Schimenti, J. C. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004471 · Cited by 76
Dnmt3a regulates both proliferation and differentiation of mouse neural stem cells
Wu, Z., Huang, K. Y., Yu, J., Le, T. T., Namihira, M., Liu, Y., Zhang, J., Xue, Z., Cheng, L., & Fan, G. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23077 · Cited by 76
Reactivation of mutant p53 by capsaicin, the major constituent of peppers
Garufi, A., Pistritto, G., Cirone, M., & D’Orazi, G. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0417-9 · Cited by 76
Geometric deep learning of protein–DNA binding specificity
Mitra, R., Li, J., Sagendorf, J. M., Jiang, Y., Cohen, A. S., Chiu, T.-P., Glasscock, C. J., & Rohs, R. (2024) · Nature Methods · doi:10.1038/s41592-024-02372-w · Cited by 75
Policing Cancer: Vitamin D Arrests the Cell Cycle
Bhoora, S., & Punchoo, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239296 · Cited by 75
Puzio‐Kuter, A. M., Xu, L., McBrayer, M. K., Dominique, R., Li, H. H., Fahr, B. J., Brown, A. M., Wiebesiek, A. E., Russo, B. M., Mulligan, C. L., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1421 · Cited by 75
Autophagy regulation in cancer development and therapy.
White, E. J., Martín, V., Liu, J.-L., Klein, S. R., Piya, S., Gomez‐Manzano, C., Fueyo-Margareto, J., & Jiang, H. (2011) · Europe PMC (PubMed Central) · Cited by 76
Jiang, D., LaGory, E. L., Brož, D. K., Bieging-Rolett, K. T., Brady, C. A., Link, N., Abrams, J., Giaccia, A. J., & Attardi, L. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.043 · Cited by 75
Role of the transcription factor Bcl11b in development and lymphomagenesis
Kominami, R. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.72 · Cited by 75
Wang, S., Chen, X. A., Hu, J., Jiang, J.-K., Li, Y., Chan-Salis, K. Y., Gu, Y., Chen, G., Thomas, C. J., Pugh, B. F., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1093-t · Cited by 75
Radioprotection: smart games with death
Gudkov, A. V., & Komarova, E. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43794 · Cited by 75
Ory, B., Ramsey, M. R., Wilson, C., Vadysirisack, D. D., Forster, N., Rocco, J. W., Rothenberg, S. M., & Ellisen, L. W. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43897 · Cited by 75
Paleček, E., Ostatná, V., Černocká, H., Joerger, A. C., & Fersht, A. R. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201006s · Cited by 75
Alonezi, S., Tusiimire, J., Wallace, J., Dufton, M. J., Parkinson, J. A., Young, L., Clements, C. J., Park, J., Jeon, J.-W., Ferro, V. A., et al. (2017) · Metabolites · doi:10.3390/metabo7020014 · Cited by 75
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers
Kumar, R., Coronel, L., Somalanka, B., Raju, A., Aning, O. A., An, Ö., Ho, Y. S., Chen, S., Mak, S. Y., Hor, P. Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05805-1 · Cited by 75
Significance of TP53 mutation in bladder cancer disease progression and drug selection
Wu, G., Wang, F., Li, K., shu-gen, L., Zhao, C., Fan, C., & Wang, J. (2019) · PeerJ · doi:10.7717/peerj.8261 · Cited by 75
Down-regulation of LATS kinases alters p53 to promote cell migrationPreprint
Furth, N., Moshe, N. B. B., Pozniak, Y., Porat, Z., Geiger, T., Domany, E., Aylon, Y., & Oren, M. (2015) · Genes & Development · doi:10.1101/gad.268185.115 · Cited by 75
Kim, Y. Y., Um, J., Yoon, J.-H., Lee, D., Lee, Y. J., Kim, D. H., Park, J., & Yun, J. (2019) · The FASEB Journal · doi:10.1096/fj.201901747rr · Cited by 74
Gotoh, T., Vila-Caballer, M., Liu, J., Schiffhauer, S., & Finkielstein, C. V. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0994 · Cited by 74
Bergeaud, M., Mathieu, L., Guillaume, A., Moll, U. M., Mignotte, B., Floch, N. L., Vayssière, J., & Rincheval, V. (2013) · Cell Cycle · doi:10.4161/cc.25870 · Cited by 74
Cubillos‐Rojas, M., Amair‐Pinedo, F., Peiró‐Jordán, R., Bartrons, R., Ventura, F., & Rosa, J. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527978 · Cited by 74
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2
Vogel, S., Bauer, M. R., Joerger, A. C., Wilcken, R., Brandt, T., Veprintsev, D. B., Rutherford, T. J., Fersht, A. R., & Boeckler, F. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215060109 · Cited by 74
Regulation of tumor suppressor p53 at the RNA level
Vilborg, A., Wilhelm, M., & Wiman, K. G. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0609-2 · Cited by 74
Alstyne, M. V., Simon, C. M., Sardi, S. P., Shihabuddin, L. S., Mentis, G. Z., & Pellizzoni, L. (2018) · Genes & Development · doi:10.1101/gad.316059.118 · Cited by 75
YPEL3, a p53-Regulated Gene that Induces Cellular Senescence
Kelley, K. D., Miller, K. R., Todd, A., Kelley, A. R., Tuttle, R., & Berberich, S. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3219 · Cited by 73
A Comprehensive and High-Resolution Genome-wide Response of p53 to Stress
Chang, G. S., Chen, X. A., Park, B., Rhee, H. S., Li, P., Han, K. H., Mishra, T., Chan-Salis, K. Y., Li, Y., Hardison, R. C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.030 · Cited by 73
Mechanisms involved in alternariol-induced cell cycle arrest
Solhaug, A., Vines, L. L., Ivanova, L., Spilsberg, B., Holme, J. A., Pestka, J. J., Collins, A. R., & Eriksen, G. S. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.09.001 · Cited by 73
Fu, L., Doorslaer, K. V., Chen, Z., Ristriani, T., Masson, M., Travé, G., & Burk, R. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012816 · Cited by 73
Auto-ubiquitination of Mdm2 Enhances Its Substrate Ubiquitin Ligase Activity
Ranaweera, R. S., & Yang, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454470 · Cited by 73
Chen, H., Yuan, Y., Zhang, C., Luo, A., Ding, F., Ma, J., Yang, S., Tian, Y., Tong, T., Zhan, Q., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326975 · Cited by 73
Spatio-temporal modelling of the Hes1 and p53-Mdm2 intracellular signalling pathways
Sturrock, M., Terry, A. J., Xirodimas, D. P., Thompson, A. M., & Chaplain, M. A. J. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.12.016 · Cited by 73
Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop
He, X., Li, Y., Dai, M., & Sun, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7479 · Cited by 73
Richards, J. S. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.01.009 · Cited by 73
Oncogenic Intra-p53 Family Member Interactions in Human Cancers
Ferraiuolo, M. A., Agostino, S. D., Blandino, G., & Strano, S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00077 · Cited by 72
Vadde, R., Radhakrishnan, S., Reddivari, L., & Vanamala, J. (2015) · BioMed Research International · doi:10.1155/2015/649263 · Cited by 72
Walton, M. I., Eve, P. D., Hayes, A., Henley, A. T., Valenti, M. R., Brandon, A. K. D. H., Box, G., Boxall, K. J., Tall, M., Swales, K. E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4919 · Cited by 72
Melero, R., Rajagopalan, S., Lázaro, M., Joerger, A. C., Brandt, T., Veprintsev, D. B., Lasso, G., Gil‐Carton, D., Scheres, S. H. W., Carazo, J. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015520107 · Cited by 72
Zeestraten, E. C. M., Benard, A., Reimers, M. S., Schouten, P. C., Liefers, G., van de Velde, C. J. �., & Kuppen, P. J. K. (2013) · Biomarkers in Cancer · doi:10.4137/bic.s11475 · Cited by 72
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
Wu, C.-C., Yang, T., Yu, C. R., Phan, L. M., Ivan, C., Sood, A. K., Hsu, S., & Lee, M. (2012) · Cell Cycle · doi:10.4161/cc.21732 · Cited by 72
Chang, H., Huang, H., Huang, T., Yang, P., Wang, Y., & Juan, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0567 · Cited by 72
p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells
He, Y., de Castro, L. F., Shin, M. H., Dubois, W., Yang, H. H., Jiang, S., Mishra, P. J., Ren, L., Gou, H., Lal, A., et al. (2014) · Stem Cells · doi:10.1002/stem.1925 · Cited by 72
XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313
Lee, M. G., Han, J., Jeong, S.-I., Her, N.-G., Lee, J., Ha, T.-K., Kang, M. J., Ryu, B., & Chi, S.-G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411746111 · Cited by 73
Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells
Zhao, J., Lü, Y., & Shen, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.040 · Cited by 72
Landscape of the SOX2 protein–protein interactome
Fang, X., Yoon, J., Li, L., Tsai, Y. S., Zheng, S. S., Hood, L., Goodlett, D. R., Foltz, G., & Lin, B. (2011) · PROTEOMICS · doi:10.1002/pmic.201000419 · Cited by 72
SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicingPreprint
Chen, Y., Zhang, L., & Jones, K. A. (2011) · Genes & Development · doi:10.1101/gad.2002611 · Cited by 72
Genetic Modifiers of the p53 PathwayPreprint
Basu, S., & Murphy, M. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026302 · Cited by 72
Yi, H., Yan, X., Luo, Q., Yuan, L., Li, B., Pan, W., Zhang, L., Chen, H., Wang, J., Zhang, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0765-8 · Cited by 71
miR‐493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver
Okamoto, K., Ishiguro, T., Midorikawa, Y., Ohata, H., Izumiya, M., Tsuchiya, N., Sato, A., Sakai, H., & Nakagama, H. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.25 · Cited by 71
Dysfunctional autophagy induced by the pro-apoptotic natural compound climacostol in tumour cells
Zecchini, S., Serafini, F. P., Catalani, E., Giovarelli, M., Coazzoli, M., Renzo, I. D., Palma, C. D., Perrotta, C., Clementi, E., Buonanno, F., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1254-x · Cited by 71
p53: A double-edged sword in tumor ferroptosis
Ji, H., Wang, W., Li, X., Han, X., Zhang, X., Wang, J., Liu, C., Huang, L., & Gao, W. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106013 · Cited by 71
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 72
p53: A tale of complexity and context
Oren, M., & Prives, C. L. (2024) · Cell · doi:10.1016/j.cell.2024.02.043 · Cited by 71
Self-citationAnnexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA
Arandkar, S., Lal, R., Khan, D., & Das, S. (2012) · RNA Biology · doi:10.4161/rna.22707 · Cited by 71
Intrinsically Disordered Proteins: Where Computation Meets Experiment
Burger, V., Gurry, T., & Stultz, C. M. (2014) · Polymers · doi:10.3390/polym6102684 · Cited by 71
Pirh2 E3 Ubiquitin Ligase Targets DNA Polymerase Eta for 20S Proteasomal Degradation
Jung, Y.-S., Liu, G., & Chen, X. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01198-09 · Cited by 71
A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation
Jiang, P., Du, W., & Yang, X. (2013) · Cell Cycle · doi:10.4161/cc.27267 · Cited by 71
Allday, M. J., Bazot, Q., & White, R. E. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_3 · Cited by 71
Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis
Prokesch, A., Graef, F. A., Madl, T., Kahlhofer, J., Heidenreich, S., Schumann, A., Moyschewitz, E., Pristoynik, P., Blaschitz, A., Knauer, M., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600845r · Cited by 71
KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis
Du, L., Kim, J. J., Shen, J., Chen, B., & Dai, N. (2017) · Oncotarget · doi:10.18632/oncotarget.14549 · Cited by 71
Extensive Post-translational Modification of Active and Inactivated Forms of Endogenous p53
DeHart, C. J., Chahal, J. S., Flint, S. J., & Perlman, D. H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030254 · Cited by 70
Regulation of the p53 pathway by ubiquitin and related proteins
Hock, A., & Vousden, K. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.011 · Cited by 70
Self-citation
Metadata
- Authors
- Vousden, K. H., & Prives, C.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Columbia University (US)
- Corresponding author
- Vousden, Karen H.
- Prives, Carol
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 137
- Issue
- 3
- Pages
- 413-431
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2133959309
- Semantic Scholar
- 018e8ed8c8694d45cfd9ffaf967368345fe22af6
- Cited by
- 3,163
- References
- 232
- Citations by year
- 2026: 128 · 2025: 154 · 2024: 127 · 2023: 168 · 2022: 149 · 2021: 166 · 2020: 175 · 2019: 149 · 2018: 171 · 2017: 191 · 2016: 228 · 2015: 202 · 2014: 258 · 2013: 263 · 2012: 228
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1538 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK
- National Cancer Institute (R01CA077742, CA77742)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, tumor suppressor, transcriptional activation, p53 activators, p53 inhibitors, p53 regulation
- MeSH terms
- Animals, Cell Survival, Cell Transformation, Neoplastic, Gene Expression Regulation, Humans, Mutation, Stress, Physiological, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review